Paediatric and Perinatal Drug Therapy

Improving research and access to children's medicines worldwide
pp. 138-139(2)
Authors: Berkovitch, Mati; Choonara, Imti; Jacqz-Aigrain, Evelyne; Kalikstad, Betty; Pons, Gerard; Rane, Anders; van den Anker, John; van Overmeire, Bart

Working with the pharmaceutical industry in relation to paediatric clinical trials. A British perspective
pp. 140-144(5)
Authors: Dewit, Odile; Tiner, Richard

How long does it take to administer oral medicines to children?
pp. 145-149(5)
Authors: Skwierczynski, Claire; Conroy, Sharon

Paediatric asthma severity score and length of stay in patients presenting to a paediatric emergency department
pp. 150-153(4)
Authors: Chu, S.; Tan, J.; Seabrook, J.A.; Rieder, M.J.

Delayed respiratory depression after accidental risperidone overdose
pp. 154-156(3)
Authors: Satish, H.P.; Payne, H.; Potter, F.; Nunn, A.J.; Brodbelt, K.

Inclusion of a previously published paper
pp. 157-157(1)

Hydroxurea treatment in sickle cell children
pp. 158-170(13)
Authors: Odièvre, Marie-Hélène; Benkerrou, Malika; Belloy, Marie; Elion, Jacques

A new partnership for drug therapy in children
pp. 171-171(1)
Authors: Choonara, Imti; Nunn, Anthony J.

Amniotic fluid disposition of cefazolin during pregnancy
pp. 172-176(5)
Authors: Allegaert, K.; Lewi, L.; Verbesselt, R.; Rayyan, M.; Doné, E.; Vanhole, C.; Devlieger, R.

Paediatric infliximab therapy: patients' and parents' perspectives on treatment options
pp. 177-181(5)
Authors: Hazen, Ankie C.M.; Smith, Felicity J.; Taylor, Kevin M.G.; Rawcliffe, Christine; Medcalf, Lucy; Keady, Simon

Special thanks
pp. 182-182(1)